F573 for Injection for the Treatment of Liver Injury/Failure

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

China

Beijing You 'an Hospital, Capital Medical University, Beijing, Beijing Municipality

Qingyuan People's Hospital (Sixth Affiliated Hospital of Guangzhou Medical University), Qingyuan, Guangdong

Shiyan City Taihe Hospital, Shiyan, Hubei

Hunan Medical College General Hospital (formerly Huaihua City First People's Hospital), Huaihua, Hunan

Pingxiang Second People's Hospital, Pingxiang, Jiangxi P

First Hospital of Jilin University, Changchun, Jilin

The Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong

Heze Municipal Hospital, Heze, Shandong

Shanxi Bethune Hospital, Taiyuan, Shanxi

Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan